Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Wilson Mark Andrew Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 4 Wilson Mark Andrew (Chief Legal Officer) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 7,221 shares @ $0.78, valued at $5.6k
05/17/2023 4 Wilson Mark Andrew (Chief Legal Officer) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 7,543 shares @ $0.72, valued at $5.4k
11/18/2022 4 Wilson Mark Andrew (Chief Legal Officer) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 8,690 shares @ $3.57, valued at $31k
08/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2022 4 Wilson Mark Andrew (SVP & General Counsel) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 3,661 shares @ $10.95, valued at $40.1k
12/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/17/2021 4 Wilson Mark Andrew (SVP & General Counsel) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Granted 20,100 shares @ $0
Sold 6,564 shares @ $13.16, valued at $86.4k
10/14/2021 4 Wilson Mark Andrew (SVP & General Counsel) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Granted 35,800 options to buy @ $21.79, valued at $780.1k
05/19/2021 4 Wilson Mark Andrew (SVP & General Counsel) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 1,917 shares @ $18.3, valued at $35.1k
02/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/22/2020 4 Wilson Mark Andrew (SVP & General Counsel) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Granted 28,550 shares @ $0
Granted 51,000 options @ $18.75, valued at $956.3k
11/18/2020 4 Wilson Mark Andrew (SVP & General Counsel) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 1,539 shares @ $16.93, valued at $26.1k
08/19/2020 4 Wilson Mark Andrew (SVP & General Counsel) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 1,529 shares @ $19.67, valued at $30.1k
05/20/2020 4 Wilson Mark Andrew (SVP & General Counsel) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 1,529 shares @ $22.51, valued at $34.4k
04/08/2020 3 Wilson Mark Andrew (SVP & General Counsel) has filed a Form 3 on NEKTAR THERAPEUTICS

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy